We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.66%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
+$44.3M
(+31%)
Cap. Flow
+$55.2M
Cap. Flow
% of AUM
29.71%
Top 10 Holdings %
Top 10 Hldgs %
58.03%
Holding
319
New
65
Increased
26
Reduced
45
Closed
58
Avg Time Held Equity + Options
3.4
quarters
Top 10 Avg Time Held Equity + Options
1.9
quarters
Top 20 Avg Time Held Equity + Options
2.4
quarters
Avg Time Held Equity only
3.4
quarters
Top 10 Avg Time Held Equity only
3
quarters
Top 20 Avg Time Held Equity only
2.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$9.83M |
| 2 |
Alibaba
BABA
|
+$2.05M |
| 3 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$1.48M |
| 4 |
Plains GP Holdings
PAGP
|
+$934K |
| 5 |
Esperion Therapeutics
ESPR
|
+$918K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualys
QLYS
|
+$931K |
| 2 |
RAX
Rackspace Hosting Inc
RAX
|
+$814K |
| 3 |
RKUS
RUCKUS WIRELESS INC COM STK (DE)
RKUS
|
+$735K |
| 4 |
DTO
DB Crude Oil Double Short Exchange Traded Notes due June 1, 2038
DTO
|
+$712K |
| 5 |
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
|
+$712K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.2% |
| 2 | Financials | 30.88% |
| 3 | Healthcare | 9.98% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Energy | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ECTE
176
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| $34K | 0.02% |
25,000
| – | – |
2013 Q2
6 quarters
|
|
177
DELISTED
Citigroup Inc
C.WS.A
| $22K | 0.01% |
25,000
| – | – |
2013 Q2
6 quarters
|
|
178
DELISTED
Cel-Sci Corp Series S
CVM.WS
| $14K | 0.01% |
100,000
| – | – |
2014 Q2
2 quarters
|
|
179
DELISTED
CASI Pharmaceuticals
CASI
| $13K | 0.01% |
1,000
-1,000
| -50% | -$15.7K |
2013 Q2
6 quarters
|
|
180
Oragenics
OGEN
$2.02M
| $9K | ﹤0.01% |
1
| – | – |
2013 Q4
4 quarters
|
|
|
DVOX
181
DELISTED
DYNAVOX INC CL A COM STK (DE)
DVOX
| $8K | ﹤0.01% |
150,000
| – | – |
2013 Q2
6 quarters
|
|
182
CALL
GSK
GSK
$94B
| $7K | ﹤0.01% |
8,000
| – | – |
2014 Q3
1 quarter
|
|
|
EMIS
183
DELISTED
EMISPHERE TECHNOLOGIES INC
EMIS
| $7K | ﹤0.01% |
25,000
| – | – |
2013 Q2
6 quarters
|
|
184
DELISTED
INDIA GLOBALIZATION CAPITAL, INC. WTS EXP 3/06/2017
IGC.WS
| $2K | ﹤0.01% |
157,798
| – | – |
2013 Q2
6 quarters
|
|
|
185
DELISTED
CITIGROUP INC WTS EXP (10/28/2018) (DE)
C.WS.B
| $1K | ﹤0.01% |
50,000
| – | – |
2013 Q2
6 quarters
|
|
186
American Homes 4 Rent
AMH
$11B
| – | – |
-25,000
| Closed | -$422K | – |
|
187
Arcturus Therapeutics
ARCT
$358M
| – | – |
-1,429
| Closed | -$154K | – |
|
188
AudioCodes
AUDC
$274M
| – | – |
-45,000
| Closed | -$216K | – |
|
189
CALL
B&G Foods
BGS
$198M
| – | – |
-50,000
| Closed | -$1.38M | – |
|
|
190
B&G Foods
BGS
$198M
| – | – |
-15,000
| Closed | -$413K | – |
|
191
Crocs
CROX
$5.6B
| – | – |
-10,000
| Closed | -$126K | – |
|
192
iShares MSCI Mexico ETF
EWW
$1.44B
| – | – |
-5,000
| Closed | -$344K | – |
|
193
PUT
GoPro
GPRO
$246M
| – | – |
-15,000
| Closed | -$1.41M | – |
|
194
Heron Therapeutics
HRTX
$78.9M
| – | – |
-10,000
| Closed | -$83K | – |
|
195
lululemon athletica
LULU
$11B
| – | – |
-10,000
| Closed | -$420K | – |
|
196
CALL
Microsoft
MSFT
$4.02T
| – | – |
-50,000
| Closed | -$2.32M | – |
|
197
Children's Place
PLCE
$29.1M
| – | – |
-10,000
| Closed | -$477K | – |
|
198
Peraso
PRSO
$5.76M
| – | – |
-7
| Closed | -$133K | – |
|
|
199
Qualys
QLYS
$6.81B
| – | – |
-35,000
| Closed | -$931K | – |
|
200
Steven Madden
SHOO
$3.27B
| – | – |
-22,500
| Closed | -$483K | – |
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q4 2014 Portfolio in Review
As of Q4 2014, E.E. Geduld held 319 positions worth $186M, up 31% from $142M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
E.E. Geduld deployed $55.2M of net new capital in Q4 2014, opening 65 new positions and adding to 26 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 25,000 shares worth $81K.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was General Motors Company, an estimated $667K trimmed.
- E.E. Geduld's largest Q4 2014 buy was Regeneron Pharmaceuticals: 25,000 shares worth $81K.
- E.E. Geduld added most to Hess in Q4 2014, an estimated $792K increase.
- E.E. Geduld's biggest Q4 2014 reduction was General Motors Company, cutting an estimated $667K.
- E.E. Geduld fully exited Qualys in Q4 2014, selling an estimated $931K.
- E.E. Geduld's ten largest holdings make up 58% of its $186M portfolio in Q4 2014.
- E.E. Geduld opened 65 new positions and closed 58 in Q4 2014.
- E.E. Geduld's portfolio value rose 31% quarter-over-quarter to $186M.
Based on E.E. Geduld's 13F filing for Q4 2014, filed 30 Jan 2015.